The CKD-MBD biochemical abnormalities include the reduction of 1,25-dihydroxyvitamin D [1,25(OH)2D], the increase in serum phosphorus and serum parathyroid hormone (PTH), and the possible reduction in serum calcium (Ca) [1]. This evidence concerns the gene PTH and Marchiafava-Bignami disease.